Summary
CVS Health Corporation announced a significant leadership transition, appointing J. David Joyner as the new President and Chief Executive Officer, effective October 17, 2024. This appointment follows the departure of Karen S. Lynch from her CEO role and resignation from the Board of Directors on the same day. Roger N. Farah, the current Chairman, will assume the role of Executive Chairman of the Board. Mr. Joyner brings extensive experience within CVS Health, most recently serving as Executive Vice President and President of Pharmacy Services. His background also includes prior roles in sales and account services within CVS Caremark. The company's announcement, filed on October 18, 2024, also includes preliminary third-quarter 2024 results, though details are incorporated by reference to a furnished press release.
Key Highlights
- 1J. David Joyner appointed President and Chief Executive Officer, effective October 17, 2024.
- 2Karen S. Lynch has stepped down as President and Chief Executive Officer and resigned from the Board of Directors.
- 3Roger N. Farah appointed as Executive Chairman of the Board.
- 4J. David Joyner has a deep background within CVS Health, including his most recent role as EVP and President of Pharmacy Services.
- 5Ms. Lynch will receive separation benefits contingent on a release of claims and compliance with restrictive covenants.
- 6Ms. Lynch will provide advisory services to CVS Health for six months post-departure, receiving a monthly fee of $375,000 and continued security services.
- 7Restrictive covenants for Ms. Lynch have been extended to 30 months from her departure date.